ARVNArvinas, Inc.
$7.52-19% 1Y
$7.52
$6.9852 weeks$13.83
Is the price fair?
What ARVN's price assumes
Arvinas, Inc. has no trailing P/E on file, so the price is measured against sales instead: 7.65× revenue.
7.65
Price / sales · no trailing P/E on file: measured against sales instead
- Price / book
- 1.77
Price / book · as of 2026-Q1
- EV / sales
- 6.77
EV / sales
Details›
- Price / bookas of 2026-Q1
- 1.77
- EV / EBIToperating margin −5.7%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q1
- 6.77
- Market capitalisation
- $485M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Biotechnology
The closest names by size in the same industry